![]() |
|
|
Forward to a colleague |
||
Access Full Stories Applied Biosystems (ABI) has exclusively licensed Olink Bioscience's proximity ligation assay (PLA) technology that enables the correlation of gene and protein expression data... Read Novartis weighs up label-free HTS for drug discovery Researchers from Novartis have published results using high-throughput screening (HTS) mass spectrometry (MS) techniques for the identification of enzyme inhibitors... Read 'In-house' outsourcing firm in line for EU accolade Synergy has been short-listed in three categories for the upcoming European Outsourcing Awards - an accolade that could give a boost to its innovative "in house" outsourcing model... Read Industry news in brief - week 40 LabTechnologist.com brings you a round up of recent industry news, with developments at Affymetrix, Celera, deltaDOT, Eksigent, Farfield, Nanogen and Olympus UK... Read Waters and Thar collaborate for greener separations Waters and Thar Instruments have agreed to deepen their collaboration to combine their strengths in mass spectrometry (MS) and super critical fluid chromatography (SFC) to make separation science 'greener'... Read |
||||||||||||||||||
All News Headlines for: October | September | August |
||||||||||||||||||
![]() Separation of polar compounds A Mini-tutorial to HILICThe ZIC®-HILIC column is the ideal choice for separation of polar and hydrophilic compounds. Amino acids, bases, peptides, carbohydrates, plant extracts and other polar compounds have good retention on the column from SeQuant - "The Number One in HILIC"... Click Here | ||||||||||||||||||
|
Related Industry News Drug theft costs industry up to $1bn a year Pharmaceutical companies not only have to face the consequences of a burgeoning counterfeit drug black market but have to contend with the theft of their own manufactured drugs for illicit uses, according to a... Read Biogen antibody regenerates MS nerves Biogen Idec is pushing forward with a therapeutic antibody that can turn myelin producing cells back on and so could reverse the damaging effects of multiple sclerosis (MS)... Read FDA told its safety monitoring of clinical trials not good enough The US Food and Drug Administration (FDA) has been called into question again after the release of a damning report, this time suggesting the agency is inadequate in its safety monitoring of clinical trials... Read Personalised medicine boosted by new cancer target A new target for anticancer drugs is over expressed in cancer cells to a much greater extent than other oncogenes, boosting the prospects of personalised therapy in the field... Read
|
||||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@LabTechnologist.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||